These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 38989740)

  • 1. The Role of TAMs in the Regulation of Tumor Cell Resistance to Chemotherapy.
    McWhorter R; Bonavida B
    Crit Rev Oncog; 2024; 29(4):97-125. PubMed ID: 38989740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting tumor-associated macrophages to reverse antitumor drug resistance.
    Li S; Sheng J; Zhang D; Qin H
    Aging (Albany NY); 2024 May; 16(11):10165-10196. PubMed ID: 38787372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
    Erin N; Grahovac J; Brozovic A; Efferth T
    Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting tumor-associated macrophages as an antitumor strategy.
    Cheng N; Bai X; Shu Y; Ahmad O; Shen P
    Biochem Pharmacol; 2021 Jan; 183():114354. PubMed ID: 33279498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy.
    Zhang SY; Song XY; Li Y; Ye LL; Zhou Q; Yang WB
    Pharmacol Res; 2020 Nov; 161():105111. PubMed ID: 33065284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-Associated Macrophages: Critical Players in Drug Resistance of Breast Cancer.
    Xiao M; He J; Yin L; Chen X; Zu X; Shen Y
    Front Immunol; 2021; 12():799428. PubMed ID: 34992609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy Enriches for Proinflammatory Macrophage Phenotypes that Support Cancer Stem-Like Cells and Disease Progression in Ovarian Cancer.
    Cruz LS; Robinson M; Stevenson D; Amador IC; Jordan GJ; Valencia S; Navarrete C; House CD
    Cancer Res Commun; 2024 Oct; 4(10):2638-2652. PubMed ID: 39287565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor-associated macrophages: A sentinel of innate immune system in tumor microenvironment gone haywire.
    Malik S; Sureka N; Ahuja S; Aden D; Zaheer S; Zaheer S
    Cell Biol Int; 2024 Oct; 48(10):1406-1449. PubMed ID: 39054741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decoding the spatiotemporal heterogeneity of tumor-associated macrophages.
    Chu X; Tian Y; Lv C
    Mol Cancer; 2024 Jul; 23(1):150. PubMed ID: 39068459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomaterials in modulating tumor-associated macrophages and enhancing immunotherapy.
    Liang C; Zhang Y; Wang S; Jiao W; Guo J; Zhang N; Liu X
    J Mater Chem B; 2024 May; 12(20):4809-4823. PubMed ID: 38695349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting tumor-associated macrophages for cancer immunotherapy.
    Shu Y; Cheng P
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188434. PubMed ID: 32956767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Tumor Associated Macrophages (TAMs) in Cancer Progression, Chemoresistance, Angiogenesis and Metastasis - Current Status.
    Dallavalasa S; Beeraka NM; Basavaraju CG; Tulimilli SV; Sadhu SP; Rajesh K; Aliev G; Madhunapantula SV
    Curr Med Chem; 2021; 28(39):8203-8236. PubMed ID: 34303328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncometabolites lactate and succinate drive pro-angiogenic macrophage response in tumors.
    Kes MMG; Van den Bossche J; Griffioen AW; Huijbers EJM
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188427. PubMed ID: 32961257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
    Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
    Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fu-Zheng-Yi-Liu Formula inhibits the stem cells and metastasis of prostate cancer via tumor-associated macrophages/C-C motif chemokine ligand 5 pathway in tumor microenvironment.
    Chen C; Huang R; Wang N; Zheng Y; Zhou J; Yang B; Wang X; Zhang J; Pan B; Chen Z; Wang S; Wang Z; Xiang S
    Chin J Nat Med; 2024 Jun; 22(6):501-514. PubMed ID: 38906598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the Depletion of M2 Macrophages: Implication in Cancer Immunotherapy.
    Festekdjian T; Bonavida B
    Crit Rev Oncog; 2024; 29(4):55-73. PubMed ID: 38989738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in Nanoimmunotherapy by Modulating Tumor-Associated Macrophages for Cancer Therapy.
    Hao J; Zhao X; Wang C; Cao X; Liu Y
    Bioconjug Chem; 2024 Jul; 35(7):867-882. PubMed ID: 38919067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of tumor-associated macrophages in tumor immune evasion.
    Huang R; Kang T; Chen S
    J Cancer Res Clin Oncol; 2024 May; 150(5):238. PubMed ID: 38713256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential therapeutic targets in myeloid cell therapy for overcoming chemoresistance and immune suppression in gastrointestinal tumors.
    Fan J; Zhu J; Zhu H; Xu H
    Crit Rev Oncol Hematol; 2024 Jun; 198():104362. PubMed ID: 38614267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.